These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 856011)

  • 1. Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.
    Carbon C; Contrepois A; Brion N; Lamotte-Barrillon S
    Antimicrob Agents Chemother; 1977 Apr; 11(4):594-8. PubMed ID: 856011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of cefazolin penetration in high- and low-protein-containing extravascular fluid: new method for performing simultaneous studies.
    Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1978 Oct; 14(4):533-8. PubMed ID: 718152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding and concentrations of cephaloridine and cefazolin in serum and interstitial fluid of dogs.
    Waterman NG; Raff MJ; Scharfenberger L; Barnwell PA
    J Infect Dis; 1976 Jun; 133(6):642-7. PubMed ID: 932492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffusion of cefotaxime in the interstitial fluid of rabbits. Comparison with cefazolin, cefoxitin and cefamandole (author's transl)].
    Boussougant Y; Contrepois A; Doquir C; Carbon C
    Nouv Presse Med; 1981 Feb; 10(8):591-3. PubMed ID: 6259599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.
    Gerding DN; Peterson LR; Legler DC; Hall WH; Schierl EA
    Antimicrob Agents Chemother; 1978 Aug; 14(2):234-9. PubMed ID: 697350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentrations of cephalosporins in tissue fluid of rats with localized infection.
    Polacek I
    Biopharm Drug Dispos; 1981; 2(1):69-77. PubMed ID: 7016213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.
    Gerding DN; Kozak AJ; Peterson LR; Hall WH
    Antimicrob Agents Chemother; 1980 Jun; 17(6):1023-9. PubMed ID: 6996611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental studies on the passage of antibiotics into cerebrospinal fluid in staphylococcal meningitis in rabbits. II. Cephaloridine, cephalothin and cefazolin (author's transl)].
    Morikawa Y; Haruta T; Fujiwara T; Kobayashi Y
    Jpn J Antibiot; 1978 Jun; 31(6):325-33. PubMed ID: 682368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of cefamandole in serum interstitial fluid, bile, and urine.
    Waterman NG; Eickenberg HU; Scharfenberger L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):733-5. PubMed ID: 984808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the transport and toxicity of cephalosporins in the kidney.
    Tune BM
    J Infect Dis; 1975 Aug; 132(2):189-94. PubMed ID: 1159324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration into inflammatory exudate and wounds of two cephalosporins for the prevention of surgical infections.
    Ellis BW; Stanbridge RD; Sikorski JM; Dudley HA
    J Antimicrob Chemother; 1975 Sep; 1(3):291-6. PubMed ID: 1184502
    [No Abstract]   [Full Text] [Related]  

  • 17. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
    Lee FH; Smyth RD; Van Harken DR
    Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1476-85. PubMed ID: 6274834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.